News|Articles|February 21, 2024
Evaluation of Novel Cell Retention Technology and Cell Culture Media for N-1 Perfused Seed Train
Author(s)Millipore Sigma
Achieve greater upstream productivity with intensified processing via a perfused seed train.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FAQ: What You Need to Know About Agentic AI in Drug Discovery
2
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
Industrial-Scale Cell Therapy Automation Gains Traction with New Cellares Funding
5